Delays to Low-risk Thyroid Cancer Treatment During COVID-19—Refocusing From What Has Been Lost to What May Be Learned and Gained

Field	Value	Language
dc.contributor.author	Nickel, Brooke	en_AU
dc.contributor.author	Glover, Anthony	en_AU
dc.contributor.author	Miller, Julie A.	en_AU
dc.date.accessioned	2021-02-09T22:29:42Z
dc.date.available	2021-02-09T22:29:42Z
dc.date.issued	2021	en_AU
dc.identifier.uri	https://hdl.handle.net/2123/24465
dc.description.abstract	This Viewpoint examines the potential benefits that delaying low-risk thyroid surgical procedures may provide for patients as the coronavirus disease 2019 pandemic continues to alter treatment timelines.	en_AU
dc.language.iso	en	en_AU
dc.subject	COVID-19	en_AU
dc.subject	Coronavirus	en_AU
dc.title	Delays to Low-risk Thyroid Cancer Treatment During COVID-19—Refocusing From What Has Been Lost to What May Be Learned and Gained	en_AU
dc.type	Article	en_AU
dc.identifier.doi	10.1001/jamaoto.2020.3878

Associated file/s

There are no files associated with this item.